Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1998-05-29
2000-09-26
Ramsuer, Robert W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
5483117, 548518, 548526, 548531, A61K 314025, A61P 900, C07D40310
Patent
active
061243418
ABSTRACT:
A compound of the formula (I): ##STR1## or a pharmaceutically acceptable salt thereof is disclosed, as well as processes for and intermediates in the preparation thereof, and a method of antagonizing endothelin.
REFERENCES:
patent: 3342833 (1967-09-01), Fremery
patent: 4132709 (1979-01-01), Santrouch et al.
patent: 4216218 (1980-08-01), Ehrgott et al.
patent: 4340715 (1982-07-01), Grounder et al.
patent: 5296494 (1994-03-01), Lavielle et al.
patent: 5482960 (1996-01-01), Berryman et al.
patent: 5767144 (1998-06-01), Winn et al.
Boyd Steven A.
Henry Kenneth J.
Jae Hwan-Soo
Sorensen Bryan K.
Tasker Andrew S.
Abbott Laboratories
Ramsuer Robert W.
Strode Janelle D.
LandOfFree
Endothelin antagonists does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Endothelin antagonists, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Endothelin antagonists will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2100682